Transfusion-transmitted babesiosis: Achieving successful mitigation while balancing cost and donor loss

Transfusion

Volumn 52, Issue 7, 2012, Pages 1404-1407

  Cushing, Melissa ^a   Shaz, Beth ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

ARM BLOOD FLOW; BABESIA; BABESIA MICROTI; BABESIOSIS; BLOOD DONOR; COST; DEATH; ERYTHROCYTE; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PARASITEMIA; REVIEW; RISK; SEROLOGY; TRANSFUSION TRANSMITTED BABESIOSIS;

ANEMIA, SICKLE CELL; ANIMALS; ANTIGENS, PROTOZOAN; BABESIA; BABESIA MICROTI; BABESIOSIS; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; DNA, PROTOZOAN; DONOR SELECTION; ENDEMIC DISEASES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; MALE; RNA, PROTOZOAN; RNA, RIBOSOMAL, 18S;

EID: 84863807030     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03746.x     Document Type: Review

References (15)

1. Johnson ST, Cable RG, Leiby DA,. Lookback investigation of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area. Transfusion 2012; 52: 1509-16.
2. Young C, Chawla A, Berardi V, Padbury J, Skowron G, Krause PJ,; the Babesia Testing Investigational Containment Study Group. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Transfusion 2012; 52: 1523-9.
3. Bloch EM, Herwaldt BL, Leiby DA, Shaieb A, Herron RM, Chervenak M, Reed W, Hunter R, Ryals R, Hagar W, Xayavong MV, Slemenda SB, Pieniazek NJ, Wilkins PP, Kiemtrup AM,. The third described case of transfusion-transmitted Babesia duncani. Transfusion 2012; 52: 1517-22.
4. US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2010. [cited 2012 Apr 30]. Available from: URL: http://www.fda.gov/biologicsbloodvaccines/ safetyavailability/reportaproblem/transfusiondonationfatalities/ucm254802.htm
5. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M,. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155: 509-20.
6. th meeting, July 26-27, 2012. [cited 2012 Apr 30]. Available from: URL: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM218994.pdf
7. Leiby DA,. Babesiosis and blood transfusion: flying under the radar. Vox Sang 2006; 90: 157-65.
8. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, Leiby DA,. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009; 49: 2557-63.
9. Borkent-Raven BA, Janssen MP, van der Poel CL, Schaasberg WP, Bonsel GJ, van Hout BA,. The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang 2010; 99: 54-64.
10. Gubernot DM, Nakhasi HL, Mied PA, Asher DM, Epstein JS, Kumar S,. Transfusion-transmitted babesiosis in the United States: summary of a workshop. Transfusion 2009; 49: 2759-71.
11. Henschler R, Seifried E, Mufti N,. Development of the S-303 pathogen inactivation technology for red blood cell concentrates. Transfus Med Hemother 2011; 38: 33-42.
12. Cancelas JA, Rugg N, Fletcher D, Pratt PG, Worsham DN, Dunn SK, Marschner S, Reddy HL, Goodrich RP,. In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion 2011; 51: 1460-8.
13. Grellier P, Benach J, Labaied M, Charneau S, Gil H, Monsalve G, Alfonso R, Sawyer L, Lin L, Steiert M, Dupuis K,. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion 2008; 48: 1676-84.
14. Blajchman MA,. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation. Transfus Clin Biol 2009; 16: 70-4.
15. Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich R, Leiby DA,. Evaluation of Babesia microti reduction with the Mirasola system for whole blood [abstract]. Transfusion 2011; 51 Suppl 3: 27A.